Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
Submitted by
admin
on September 8, 2016 - 9:50am
Source:
24/7 Wall St
News Tags:
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
Headline:
Key FDA Decisions and Trial Results Expected in October
